Company Quick10K Filing
Data Call Technologies
10-Q 2020-03-31 Filed 2020-05-14
10-K 2019-12-31 Filed 2020-03-27
10-Q 2019-09-30 Filed 2019-11-08
10-Q 2019-06-30 Filed 2019-08-09
10-Q 2019-03-31 Filed 2019-05-10
10-K 2018-12-31 Filed 2019-03-08
10-Q 2018-09-30 Filed 2018-11-02
10-Q 2018-06-30 Filed 2018-07-27
10-Q 2018-03-31 Filed 2018-05-11
10-K 2017-12-31 Filed 2018-03-08
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-04-12
10-Q 2016-09-30 Filed 2016-10-25
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-10
10-K 2015-12-31 Filed 2016-02-26
10-Q 2015-09-30 Filed 2015-11-06
10-Q 2015-06-30 Filed 2015-08-03
10-Q 2015-03-31 Filed 2015-04-30
10-K 2014-12-31 Filed 2015-03-30
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-01
10-Q 2014-03-31 Filed 2014-05-12
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-08
10-Q 2013-06-30 Filed 2013-08-12
10-Q 2013-03-31 Filed 2013-05-06
10-K 2012-12-31 Filed 2013-03-27
10-Q 2012-09-30 Filed 2012-11-07
10-Q 2012-06-30 Filed 2012-08-06
10-Q 2012-03-31 Filed 2012-05-14
10-K 2011-12-31 Filed 2012-04-13
10-Q 2011-09-30 Filed 2011-11-18
10-Q 2011-06-30 Filed 2011-08-19
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-04-13
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-20
10-Q 2010-03-31 Filed 2010-05-20
10-K 2009-12-31 Filed 2010-03-31

Data Call Technologies Financials

DCLT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Kibush Capital (DLCR) 0 33% -0.2 -213% 178 3,452 140 46 -380 -374 88
Alkame Holdings (ALKM) 0 11% -0.0 -2,776% 97 4,532 124 13 -2,695 -2,645 0
Vilacto Bio (VIBI) 0 17% -0.0 -3,636% 538 3,960 5 1 -19,550 -19,519 17
Daniels Corporate Advisory (DCAC) 0 22% -0.4 50% 547 2,757 2,368 525 271 343 -129
Ironclad Encryption (IRNC) 0 0.0 -1,440% 585 5,116 0 0 -8,421 -7,101 -150
Mercantil Bank Holding (MBHC) 0 -1.3 0% 8,435,802 7,708,127 0 0 21,974 81,045 -103,579
Jiayin Group (JFIN)
Cerebain Biotech (CBBT) 0 -2.4 -7,969% 22 6,686 0 0 -1,718 -1,399 3,294
HyperSolar (HYSR) 0 1.4 131% 174 6,528 0 0 228 1,247 1,711
Rennova Health (RNVA) 0 8% -1.3 -236% 16,574 76,464 13,138 1,065 -39,132 -22,172 28,583
Yinghong Guangda Technology (UBLI) 0 24% 0.0 0 21 1,377 326 -1,329 -1,280 -0
ProGreen (PGUS) 0 0% -0.1 -176% 1,863 6,266 61 0 -3,277 -210 17
PropTech Acquisition Corp (PTACU)
9F (JFU)
Data Call Technologies (DCLT) 0 70% 0.7 -21% 101 73 463 323 -21 -19 -13
Ozop Surgical (OZSC) 0 90% -0.7 -71% 6,256 10,414 85 76 -4,437 -2,958 1,985
Intercloud Systems (ICLD) 0 21% -1.3 -92% 9,928 40,762 10,074 2,119 -9,147 -8,136 10,297
PetLife Pharmaceuticals (PTLF) 0 -0.1 -47,202% 8 1,981 0 0 -3,708 -3,708 205
Futu (FHL)
OriginClear (OCLN) 0 11% -0.4 -648% 1,287 20,610 2,696 290 -8,338 -7,771 3,125

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash45111431215153641707871335965759086707272531025654542364723111813
Accounts Receivable4749473175239692035438103115977673578672796911072767386737281877571
Inventory
PP&E5412131211211216129129129129129129129129129129129129129129129129137145145146146146146146146
Assets1841011771107233921311794210137113139180177166178157159155162142122101162133136124143125105112101
Accounts Payable62679-93620333427351927203025341824172115222824
Long-Term Debt10
Liabilities38031527744129423931020314112712611810210791108919182978311188101729081858073
Stockholders' Equity-202-227-145-115459637166516471662418504536535245203128
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue141112166161148124123157157153163167165166174162143154147168159168146152148162151168160145164162137
Cost of Revenue3031292629313327353535394242354136373640394248445046
Gross Profit1121301291311241321341381311271071141051261241271161111251101291189711911291
R&D
SG&A12212191258131150138144144212144202156161160193162163165194161132157151999614310095
Tax0000000
Net Income-203-13-84-4-77-51-48-57-67-39-38-57-79-92-13-51-2617-1-2610-6
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-183867-69-313157-68-27287-4-382781218-3-1442-17-421751-11-097-87-1110-3
Cash Investing00-5-20000000000-9-800-1000
Cash Financing2000-13-20-20-20-9-30-1-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2